What is BioLife Solutions's EV / EBITDA?

BioLife Solutions (BLFS) reported EV / EBITDA of 472.2× in Q1 2025.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

BioLife Solutions BLFS EV / EBITDA

EV / EBITDA at other companies

Thermo Fisher ScientificTMO

21.3×-3.5×

DanaherDHR

20.5×-2.1×

AzentaAZTA

201.8×-211×

TEC

Bio-TechneTECH

33.8×+2.6×

RevvityRVTY

16.7×-2.2×

Charles River LaboratoriesCRL

16.2×+2.9×

Other financials

Income statement

See full

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

See full

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

See full

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

See full

Market cap$1.38B+34.4%

Enterprise value$1.37B+35.0%

P/S13.8×+1.6×

Profitability

See full

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

See full

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

enterprise value/ebitda=472.2×

Based on the most recent quarter.

The official record: BioLife Solutions’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioLife Solutions's EV / EBITDA?: BioLife Solutions (BLFS) reported EV / EBITDA of 472.2× in Q1 2025.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.